Keyphrases
AIDS/HIV
100%
Single-dose Nevirapine
100%
Antiretroviral Therapy
100%
Treatment Optimization
100%
South African Women
100%
Nevirapine
77%
Lopinavir
50%
Cost-effectiveness
22%
Nevirapine Resistance
22%
Survival Time
16%
Life Expectancy
16%
Lifesaving
16%
South Africa
11%
Antiretroviral Therapy Regimens
11%
High Cost
5%
Treatment Strategy
5%
Improved Survival
5%
Reduced Survival
5%
Viral Suppression
5%
Simulation Model
5%
Past Exposure
5%
Sequential Regimen
5%
Nursing and Health Professions
Human Immunodeficiency Virus
100%
Single Drug Dose
100%
Nevirapine
100%
Antiretroviral Therapy
100%
Lopinavir Plus Ritonavir
45%
Cost Effectiveness Analysis
20%
Survival Time
15%
Life Expectancy
15%
South Africa
10%
Prevalence
5%
Pharmacology, Toxicology and Pharmaceutical Science
HIV
100%
Nevirapine
100%
Lopinavir Plus Ritonavir
45%
Survival Time
15%
Life Expectancy
15%
Prevalence
5%